SIPSIP.COM - Online Magazine

  • Biotech experts want FDA drug reviews based on science, not politics

    Biotech experts and industry executives are calling plans by the U.S. Food and Drug Administration — hit by job cuts last year — to hire thousands of employees and update clinical-trial standards encouraging, but want ​assurance that politics will not interfere in the agency's drug-review process.